BlackRock’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Buy |
4,485,828
+179,617
| +4% | +$444K | ﹤0.01% | 3307 |
|
|
2025
Q1 | $8.57M | Sell |
4,306,211
-218,573
| -5% | -$435K | ﹤0.01% | 3352 |
|
|
2024
Q4 | $13.2M | Sell |
4,524,784
-741,991
| -14% | -$2.17M | ﹤0.01% | 3233 |
|
|
2024
Q3 | $20.4M | Buy |
5,266,775
+156,357
| +3% | +$605K | ﹤0.01% | 2988 |
|
|
2024
Q2 | $26.3M | Buy |
5,110,418
+1,354,208
| +36% | +$6.96M | ﹤0.01% | 2771 |
|
|
2024
Q1 | $26.3M | Sell |
3,756,210
-22,408
| -0.6% | -$157K | ﹤0.01% | 2776 |
|
|
2023
Q4 | $33.5M | Buy |
3,778,618
+444,093
| +13% | +$3.93M | ﹤0.01% | 2682 |
|
|
2023
Q3 | $31.8M | Buy |
3,334,525
+445,309
| +15% | +$4.25M | ﹤0.01% | 2629 |
|
|
2023
Q2 | $42.3M | Buy |
2,889,216
+1,375,093
| +91% | +$20.1M | ﹤0.01% | 2541 |
|
|
2023
Q1 | $18.6M | Buy |
1,514,123
+26,277
| +2% | +$323K | ﹤0.01% | 2955 |
|
|
2022
Q4 | $27.6M | Buy |
+1,487,846
| New | +$27.6M | ﹤0.01% | 2809 |
|